Indivior Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Indivior Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Indivior Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Indivior Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Indivior Pharmaceuticals Inc (Indivior) develops, manufactures, and sells buprenorphine-based prescription pharmaceuticals for the treatment of opioid dependence. The focus on R&D activities, lead product Sublocade, and diverse product portfolio are its strengths, even as limited geographic revenue diversification and discontinuation of product development are major causes for concern for the company. Indivior could benefit from leveraging technological advancements, expansion into emerging Markets, and regulatory approvals. However, dependence on third-party payors, government regulations, and huge competition could affect the company's growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer